RecruitingNCT05756244
PRospective Evaluation of Peripartum Anticoagulation ManaGement for ThrOmboembolism
A Prospective Cohort Study Evaluating Peripartum Anticoagulation Management Among Pregnant Women With Venous Thromboembolism and Its Impact on Patient Outcomes
Sponsor
University of Calgary
Enrollment
825 participants
Start Date
Apr 4, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
The PREP and GO study is an international multicentre prospective cohort evaluating anticoagulation management strategies around labor and delivery and the postpartum period.
Eligibility
Sex: FEMALEMin Age: 18 YearsMax Age: 60 Years
Inclusion Criteria7
- years of age or older
- Requires anticoagulation during the antepartum period of pregnancy for a VTE indication, including at least one of:
- Objectively confirmed VTE (DVT, superficial vein thrombosis \[SVT\], PE or unusual site thrombosis) diagnosed during the current pregnancy;
- Objectively confirmed VTE diagnosed in a prior pregnancy;
- Objectively confirmed VTE diagnosed when not pregnant;
- Inherited or acquired thrombophilia requiring anticoagulation.
- Receiving any dose or type of LMWH during the antepartum period
Exclusion Criteria3
- Anticoagulation for a non-VTE indication, including prosthetic heart valves, atrial fibrillation, prevention of placenta-mediated pregnancy complications, or prevention of recurrent pregnancy loss (participants can be included with a diagnosis of antiphospholipid syndrome (APS) with or without thrombotic events)
- Unable to provide or declined consent.
- Home or birthing centre planned delivery.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(14)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05756244
Related Trials
Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixibat During Pregnancy and/or Lactation
NCT062589021 location
DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis
NCT0570191764 locations
Development and Application of a Thrombosis Risk Prediction Model in Lung Cancer Patients Treated With Immune Checkpoint Inhibitors
NCT069506975 locations
Rigorous Evaluation of Yes and Know, a Fully Virtual Sexual Health and Well-Being Intervention for Youth
NCT065815361 location
Evaluation of the SCALED (SCaling AcceptabLE cDs)
NCT056282071 location